29
Sat, Apr
19 New Articles

Ferring acquires ex-U.S. assets and rights for Vitaros , Apricus’ on-demand topical cream for erectile dysfunction

Industry Reports
Typography

Ferring Pharmaceuticals announced an agreement with Apricus Biosciences, Inc, granting Ferring global assets and rights, excluding the U.S., related to Apricus’ Vitaros.

Vitaros is an on-demand topical cream indicated for the treatment of patients with erectile dysfunction.Ferring is Apricus’ existing commercialisation partner for Vitaros in Latin America and parts of Europe and Asia. Following an agreed handover period, Ferring will be responsible for managing all Vitaros-related activities outside of the U.S. with existing Vitaros commercialisation partners. Apricus will retain its Vitaros rights in the U.S.

"Urology is a key therapeutic area for Ferring," said Michel Pettigrew, President of the Executive Board and COO, Ferring Pharmaceuticals. “This agreement strengthens our existing portfolio and reinforces Ferring’s commitment to improving the quality of life of patients with a broad range of urological conditions.”

About Ferring Pharmaceuticals
Headquartered in Saint-Prex, Switzerland, Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group active in global markets. The company identifies, develops and markets innovative products in the areas of reproductive health, urology, gastroenterology, endocrinology and orthopedics. Ferring has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries. For further information on Ferring or its products, visit www.ferring.com. 

*Vitaros® is a registered trademark of NexMed International Limited, and will be assigned to Ferring B.V. worldwide, excluding the United States.  Such trademark is registered in certain countries throughout the world and pending registration in the United States.

For more information:
Ferring Pharmaceuticals
Lindsey Rodger
Tel. +41 58 451 40 23
This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Market Movers

Rogers Corporation

NYQ : ROG - 28 Apr, 4:02pm
102.94
+0.36 (+0.35%) After Hours:
Open 103.61 Mktcap 1.86B
High 106.20 52wk Hight 106.20
Low 102.84 52wk Low 51.98
Vol 254103 Avg Vol 130519
Eps 5.03 P/e 38.85
Currency: USD

Banco Santander, S.A. Sponsored

NYQ : SAN - 28 Apr, 4:01pm
6.52
+0.07 (+1.09%) After Hours:
Open 6.59 Mktcap 95.07B
High 6.60 52wk Hight 6.63
Low 6.51 52wk Low 3.60
Vol 6.75M Avg Vol 7.11M
Eps 0.49 P/e 14.95
Currency: USD

Merck & Company, Inc. (new)

NYQ : MRK - 28 Apr, 4:00pm
62.33
-0.25 (-0.40%) After Hours:
Open 62.58 Mktcap 171.13B
High 62.65 52wk Hight 66.80
Low 62.14 52wk Low 53.06
Vol 9.46M Avg Vol 9.03M
Eps 3.81 P/e 44.21
Currency: USD

Johnson & Johnson

NYQ : JNJ - 28 Apr, 4:02pm
123.47
-0.27 (-0.22%) After Hours:
Open 123.85 Mktcap 335.02B
High 123.90 52wk Hight 129.00
Low 123.13 52wk Low 109.32
Vol 4.38M Avg Vol 6.70M
Eps 7.10 P/e 20.75
Currency: USD

Pfizer, Inc.

NYQ : PFE - 28 Apr, 4:01pm
33.92
+0.06 (+0.18%) After Hours:
Open 33.88 Mktcap 201.89B
High 33.94 52wk Hight 37.39
Low 33.75 52wk Low 29.83
Vol 15.98M Avg Vol 23.05M
Eps 2.55 P/e 28.92
Currency: USD

Direxion Daily 10-Yr Treasury B

PCX : TYO - 28 Apr, 8:00pm
14.32
-0.05 (-0.35%) After Hours:
Open 14.42 Mktcap
High 14.42 52wk Hight 16.29
Low 14.30 52wk Low 12.60
Vol 17778 Avg Vol 10849
Eps P/e
Currency: USD
Sign up via our free email subscription service to receive notifications when new information is available.
captcha